Get Premium to unlock powerful stock data
NAS:GBT (USA)  
Global Blood Therapeutics Inc logo

Global Blood Therapeutics Inc

$ 32.80 +0.85 (+2.66%) 08:08 PM EST
P/E:
At Loss
P/B:
15.92
Market Cap:
$ 2.14B
Enterprise V:
$ 2.24B
Volume:
1.25M
Avg Vol (2M):
1.79M
Also Trade In:
Volume:
1.25M
Market Cap $:
2.14B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.79M
Enterprise Value $:
2.24B
PB Ratio:
15.92
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Global Blood Therapeutics Inc
NAICS : 325411 SIC : 2834
181 Oyster Point Boulevard, South San Francisco, CA, USA, 94080
Description
Global Blood Therapeutics Inc operates in the healthcare sector of the United States. It discovers and develops novel therapeutics to address blood-based disorders. GBT440, its lead drug candidate targets the underlying mechanism of red blood cell (RBC) sickling, which provides the potential to treat sickle cell disease. GBT440. an oral, once-daily therapy arrests abnormal hemoglobin polymerization, the underlying mechanism of RBC sickling. In addition, the company is engaged in other research and development activities targeted at hereditary angioedema and owns exclusively licensed rights to its portfolio of product candidates in the United States, Europe, and other major markets.
Name Current Vs Industry Vs History
Cash-To-Debt 0.84
Equity-to-Asset 0.15
Debt-to-Equity 4.92
Debt-to-EBITDA -2.35
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -0.5
Distress
Grey
Safe
Beneish M-Score 6.35
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 77.21
9-Day RSI 72.75
14-Day RSI 66.81
6-1 Month Momentum % -17.94
12-1 Month Momentum % -35.67

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.52
Quick Ratio 7.74
Cash Ratio 6.98
Days Inventory 5049.2
Days Sales Outstanding 40.93
Days Payable 939.44

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.1

Financials (Next Earnings Date:2022-08-03 Est.)

GBT's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:GBT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 210.866
EPS (TTM) ($) -4.87
Beta 1.37
Volatility % 70.32
14-Day RSI 66.81
14-Day ATR ($) 2.034796
20-Day SMA ($) 27.0045
12-1 Month Momentum % -35.67
52-Week Range ($) 21.65 - 40.69
Shares Outstanding (Mil) 65.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Global Blood Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More